Outpatient pre-operative COVID-19 testing will be suspended Feb. 7
Last month, we resumed pre-operative COVID-19 testing due to the omicron surge. We have seen a dramatic drop in COVID-19 cases and test positivity rate. Asymptomatic pre-operative test positivity rate for the last seven days has been below 3%, our threshold to stop pre-operative testing for outpatient procedures.
As a result, we have decided to suspend pre-operative COVID-19 testing for asymptomatic outpatients, regardless of vaccination status, effective Monday, Feb. 7, 2022.This change applies to all Ohio hospitals and ambulatory surgery centers with current point of care COVID-19 testing capabilities.
Details to know
- We will no longer use the Lucira point-of-care, nucleic acid amplification test platform.
- We will maintain pre-operative testing for patients scheduled to come in (TCI) and inpatient surgeries and procedures, as well as select higher aerosol generating procedures using PCR platform testing.
- Patients requiring a COVID-19 test will have the option of a scheduled PCR test or SelfCheck(TM). For more details, refer to this complete list of surgeries and procedures requiring a COVID-19 test.
- If an outpatient is possibly symptomatic for COVID-19 upon presentation for surgery, COVID-19 testing may be offered using a PCR platform or referral back to their primary care physician are possible options.
Locations that have been conducting point-of-care testing will be provided with additional instructions for reverting testing operations.
We will continue to follow personal protective equipment guidelines in procedural areas, and monitor testing indicators and thresholds to maintain our safe environment of care.
If you have questions, please contact email@example.com.